Synonyms: BC-3781 | BC3781 | compound 7 [PMID: 24874438] | Xenleta®
lefamulin is an approved drug (FDA (2019), EMA (2020))
Compound class:
Synthetic organic
|
|
No information available. |
Summary of Clinical Use |
Lefamulin was approved by the FDA in 2019 as an oral and intravenous treatment for community-acquired bacterial pneumonia (CABP). |
External links |
For extended ADME data see the following: Drugs.com |